Literature DB >> 14699468

Continuous infusion of amphotericin B deoxycholate: a cost-effective gold standard for therapy of invasive fungal infections?

Markus Schneemann, Esther B Bachli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14699468     DOI： 10.1086/380843

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  2 in total

1.  Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?

Authors:  Rafael Zaragoza; Javier Pemán; Miguel Salavert; Angel Viudes; Amparo Solé; Isidro Jarque; Emilio Monte; Eva Romá; Emilia Cantón
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

2.  Comparison of adverse events and hospital length of stay associated with various amphotericin B formulations: sequential conventional amphotericin b/lipid versus lipid-only therapy for the treatment of invasive fungal infections in hospitalized patients.

Authors:  Rolin L Wade; Paresh Chaudhari; Jaime L Natoli; Robert J Taylor; Brian H Nathanson; David Horn
Journal:  P T       Date:  2013-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.